In contrast to previous studies [39–41], no difference was also noted between MIF in EPP and cohort A. In one study, there was a difference in MIF levels between controls and patients who were naïve or not treated with AP for more than 6 weeks prior to sample collection [39]. The gene discussed is MIF; the disease is alkaline phosphatase measurement.